Plant organ: Leaf
Optimal ranges of biochemical composition:
- 1,8-Cineole (Eucalyptol) 58-85%
- Alpha-pinene 10-22%
- Aromandrene 1-5%
- Para-Cymene 1-5%
- Trans-Pinocarveol 1-5%
- Globulol 0.5-1.5%.
correct traditional indications
Dermatitis of bacterial origin or Candida albicans
Warnings on the use of essential oils: The information on traditional use is not a substitute for the advice of a pharmacist or a doctor specialized in aromatherapy. Its use without attending to said recommendation will always be under your responsibility. If in doubt, it is recommended to consult your doctor. It is important to confirm the diagnosis of your disease or condition to make the best decision. It is especially important to review the contraindications and precautions for use of each essential oil. The indications and contraindications of an essential oil depend on its molecular composition. The traditional uses reported refer to essential oils and 100% pure vegetable oils with detailed information on origin, quality and specific molecular composition ranges for a SAFE AND EFFECTIVE AROMATHERAPY. THEY DO NOT APPLY TO ANY ESSENTIAL OIL THAT DOES NOT COMPLY WITH THIS INFORMATION! AROMATMA SAS is not responsible for inappropriate and/or abusive use of essential oils and vegetable oils. Allergy: Before using an essential oil, it is advisable to apply a drop on the inside of the elbow and wait 24 hours in order to demonstrate a possible allergic reaction. It is appropriate to consult the chapter entitled "Risks of using essential oil" if the icon "Allergy risks" appears.
Do not apply during pregnancy or during lactation. Do not apply to babies or children under 6 years of age. Do not apply to patients with asthma, Parkinson's or epilepsy.
Do not apply neat; For its topical application, dilute it in a vegetable oil in a maximum proportion equivalent to 20%. Do not apply pure in diffusion; Mix it with another essential oil (Lemon) in a maximum proportion equivalent to 20%.
Permitted use according to age or condition of the patient:
- Pregnancy less than 3 months: no
- Children from 3 to 6 years old: no
- Babies under 3 years old: no
Safe application routes:
- Inhalation: yes
- Topically: yes
- Oral route: no
- In diffuser: yes
Risks of using essential oil:
- Photosensitizer: no
- Hormonal interaction with estrogen: no
- General hormonal interaction: no
- Liver toxicity: no
- Neurotoxicity: yes
- Irritating to the respiratory tract: yes
- Allergy risk: no
- Dermocaustic (burns the skin if used neat): no
- Skin irritation if used neat: yes
- Cortisone-like effect: yes
General information and properties:
Eucalyptus Globulus essential oil, along with Eucalyptus Radiata essential oil, are widely known and recommended to treat respiratory system conditions. Its anti-infective activity related to the presence of alpha-pinene, together with its mucolytic and expectorant power related to the presence of alpha-pinene and 1,8-cineole (eucalyptol) are especially suitable for the treatment of diseases such as bronchitis, sinusitis and greasy cough among other conditions of the respiratory system. Eucalyptus Globulus essential oil is specifically recommended for adults, while Eucalyptus Radiata is recommended for children. 1.8 cineole increases the ciliary motor activity of the respiratory tree, stimulating the efficient expulsion of mucus. Eucalyptol inhibits inflammatory mediators such as tumor necrosis factor TNF-α, interleukin-1β, leukotriene B4, inhibition of 5-lipoxygenase and development of Prostaglandins PGE2. These actions contribute to reduce the inflammatory processes commonly treated by steroids. During a clinical trial with a patient treated with prednisolone, the administration of eucalyptol made it possible to reduce the dose of prednisolone, demonstrating an activity similar to that of steroids in obstructive respiratory diseases such as asthma. It should be noted that eucalyptol does not have the side effects of steroids. Animal research warns that the indications of Eucalyptus Globulus for conditions of the respiratory system are probably related to its ability to reduce the activity of the TLR4 receptor in the bronchioles and the excess production of mucus caused by lipopolysaccharides. Spasmolytic and bronchodilator activity. In obstructive pathologies of the respiratory tree, such as asthma or obstructive pulmonary disease (BCPO), the bronchi contract, inflame, and hypersecrete mucus. Eucalyptus essential oils rich in 1,8-cineole have a spasmolytic effect on smooth muscle fibers: in a context of respiratory obstruction, this muscle-relaxing effect produces beneficial dilation of the bronchi for the patient.
Decongestant and antitussive activity.
The anti-inflammatory and expectorant effects are generated by the rebound effect:
Decreased mucus production and therefore dryness of the nasal and bronchial passages. a decrease in the frequency of coughs associated with infectious conditions of the respiratory tract, such as colds and nasopharyngitis, or with inflammatory diseases such as asthma. Eucalyptol has proven antibacterial activity against various species of Staphylococcus sp. and alpha-pinene against the bacteria Staphylococcus aureus, Escherichia coli and Klebsiella pneumoniae and the fungi Candida albicans and Saccharomyces cerevisiae. Both molecules are involved in defense mechanisms against parasites and viruses.
Dermatitis of bacterial origin or Candida albicans
- De la Charie, T. et al. Website « Compagnie des Sens » – https://www.compagnie-des-sens.fr/
- Franchomme, P., R. Jollois, and D. Pénoël. 2001. L'aromathérapie Exactly. Encyclopédie de L'utilisation Thérapeutique Des Huiles Essentielles. Editions Roger Jollois.
- Zhiri A., Baudoux D. Huiles essentielles chémotypées et leurs synergies.
- Passport Santé. Website https://www.passeportsante.net/
- Scott A. Johnson, 2015. Evidence-based essential oil therapy the ultimate guide to the therapeutic and clinical application of essential oils (EBEO)
Image source: https://es.m.wikipedia.org/wiki/Archivo:Eucalyptus_ghj.jpg